Market Digest: NVO, BAC, USB, HLT

Related Posts

Fermion and Simcere Enter into Exclusive License and Collaboration Agreement for First SSTR4 Agonist Disease Targeting in China Via Investing.com

GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceuticals (TADAUL:) Group Limited (HKEX: 2096) announced a partnership to develop a clinical-stage disease treatment asset,…

“We have a well-defined process…”: Infosys CEO on workplace walkouts and whistleblowing

Infosys CEO Salil Parekh has responded to allegations of toxic work culture leveled by a former employee, the viral LinkedIn post sparking a wide-ranging debate. “Within Infosys, we have a…

Leave a Reply

Your email address will not be published. Required fields are marked *